Today: 9 June 2026
Pitney Bowes NT 43 drops 3% today as Treasury yields rise — what’s next for PBI.PRB
31 December 2025
2 mins read

Pitney Bowes NT 43 drops 3% today as Treasury yields rise — what’s next for PBI.PRB

NEW YORK, December 31, 2025, 14:16 ET — Regular session

Pitney Bowes Inc.’s NT 43 — its exchange-listed notes due 2043 — fell 3.0% to $21.04 in afternoon trading on Wednesday, after opening at $21.65. The security traded between $21.00 and $21.72, with volume around 50,000 shares as U.S. 10-year yields moved higher.

The move matters because NT 43 trades like a stock but behaves like a bond: when market interest rates rise, fixed-rate income securities often fall as investors demand a higher yield. Liquidity can also thin late in the year, amplifying price swings in niche, income-focused listings.

Bond markets are also on a shortened schedule into the holiday. The Securities Industry and Financial Markets Association (SIFMA) recommended a 2:00 p.m. ET early close for U.S. dollar-denominated fixed-income trading on Wednesday and a full close on Thursday for New Year’s Day, which can reduce price discovery for rate-sensitive products.

NT 43 refers to Pitney Bowes’ 6.70% Notes due 2043 — a fixed-rate corporate note listed on the New York Stock Exchange under the symbol PBI.PRB. “Coupon” is bond shorthand for the fixed interest rate the issuer pays on the note’s face value. SEC

The decline also comes after a firmer prior session. The notes closed Tuesday at $21.69 after trading as high as $21.80, according to historical pricing data.

Company-specific headlines have been sparse this week, but the 2043 notes remain on investors’ radar after Pitney Bowes completed a cash tender offer earlier this month. A company press release filed with the SEC said the tender offers expired Dec. 19 and that Pitney Bowes accepted $75.7 million of its 6.70% notes due 2043 for purchase, out of $425 million outstanding as of the offer document date.

In the equity, Pitney Bowes’ common shares were down 0.85% at $10.56 on Wednesday, data showed. Barchart listed the company’s next earnings date as Feb. 10, 2026 — a focal point for investors watching cash generation and leverage, which can influence pricing across the capital structure.

At Wednesday’s price near $21 on a $25-par note, the current cash yield sits around the high-single-digits, based on the 6.70% coupon. That income buffer can support prices when rates stabilize, but it does not eliminate sensitivity to both Treasury yields and issuer credit risk.

Traders in exchange-listed notes typically watch two things: the direction of benchmark rates and any signs of changing credit perception. A sharp move in either can show up quickly in securities like NT 43, which can trade with wider bid-ask spreads than large-cap common stocks.

Macro events are the next big test for the rates backdrop. The Bureau of Labor Statistics schedules the December 2025 U.S. employment report for Jan. 9, while the Federal Reserve’s calendar shows its next rate decision on Jan. 28, following the Jan. 27–28 FOMC meeting.

Technically, investors are likely to keep an eye on the $21 area after Wednesday’s dip toward $21.00, with the recent $21.80 zone standing out as a nearby ceiling from late December trading. A sustained break below support would put more focus on whether the year-end rate move is extending or fading.

Stock Market Today

  • Should You Buy SpaceX Stock? Key Facts on the Historic $1.77 Trillion IPO
    June 9, 2026, 10:00 AM EDT. SpaceX plans the largest-ever IPO, pricing shares at $135 with a valuation of $1.77 trillion. The company spans high-growth sectors: rocket launches, Starlink internet, AI platform Grok, and chipmaking. It reported nearly $18.7 billion in 2025 revenue but posted a $2.6 billion loss largely from R&D costs. About 555.6 million shares, or 4% of the company, will be publicly available. Elon Musk allocated up to 30% of shares to brokers like Fidelity and Robinhood to offer retail investors access. IPO stocks often surge initially but can fall below IPO price soon after. Caution advised for new investors considering immediate purchase.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading
Next Story

Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading

Go toTop